Skip to main content

Year: 2021

Terranet Unveils State of the Art Showroom in Stuttgart

Auto safety tech company debuts innovative, demo space, creating an interactive experience to showcase its revolutionary technology in the heart of Europe’s auto hub Lund, Sweden, Nov 9 2021 – Terranet AB (Terranet/the Company), (Nasdaq: TERRNT-B.ST), developers of automotive safety technologies including VoxelFlow™, today announced the opening of its new showroom in Stuttgart, Germany. As Terranet’s first private demo space, the showroom represents a new era of expansion for the rapidly growing tech company. Well on its way to becoming the European leader in automotive safety, its new location in Stuttgart will enhance Terranet’s access to some of the greatest brands and minds in the automotive industry. Terranet is moreover debuting new updates to VoxelFlow™, notably its shift from using three cameras to two. Furthermore, an autocalibration...

Continue reading

Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Enrollment in ENHANCE-1 48-week subset and ENHANCE-2 expected to complete around year-end 2021 ENHANCE Phase 3 program on track to report top-line data in 2022 Conference call today at 9:00 a.m. EST / 2:00 p.m. GMT LONDON and RALEIGH, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended September 30, 2021, and provides a corporate update. “During the third quarter, we continued to make substantial progress on patient recruitment in our Phase 3 ENHANCE (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) clinical program,” said David Zaccardelli, Pharm. D., President and Chief Executive Officer. “We are excited to report patient enrollment...

Continue reading

SERSTECH AB: Third Quarter Report 1 January – 30 September 2021

Serstech Group Third Quarter 2021 Net sales: KSEK 1 516 (8 213) Profit for the period: KSEK -5 074 (2 076) Earnings per share SEK -0.06 (0.03) Earnings per average number of shares: SEK -0.06 (0.03) Serstech Group Period 1 January – 30 September 2021 Net sales: KSEK 15 740 (14 534) Profit for the period: KSEK -7 347 (-7 948) Earnings per share SEK -0.09 (-0.11) Earnings per average number of shares: SEK -0.09 (-0.11) Parts of the world is slowly starting to open up, but many of Serstech’s target markets remain hard to access for us due to Covid restrictions. Historically, we have been most successful in South-East Asia, but for the last 18 months, we have not been able to visit customers or partners in that important region. Our local salespeople have been able to have some meetings in North America and China, even though many potential...

Continue reading

Construction contract (Viljandi Aken ja Uks AS production facilities)

AS Nordecon group company Embach Ehitus OÜ entered into contract with Viljandi Aken ja Uks AS for the design and construction of the extension of the company’s production facilities in Raua str, Viljandi. A one-storey production area and a two-storey section of utility and office space will be built, the closed net area of the extension being 8,172 sqm. The building will be completed in September 2022. Nordecon (www.nordecon.com) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment. Geographically the Group operates in Estonia, Finland, Ukraine and Sweden. The parent of the Group is Nordecon AS, a company registered and located in Tallinn, Estonia. The consolidated revenue of the Group in 2020 was 296 million euros. Currently Nordecon...

Continue reading

Progress on share buyback programme

Progress on share buyback programme ING announced today that, in line with the launch of its €1,744 million share buyback programme announced on 1 October 2021, the company has repurchased 3,451,361 shares during the week of 1 November 2021 up to and including 5 November 2021. The shares were repurchased at an average price of €13.36 for a total amount of €46,116,383.43. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at  https://www.ing.com/Investor-relations/Share-information/Share-buyback-programme.htm. The total number of shares repurchased under this programme to date is 35,036,143 ordinary shares at an average price of €12.91 for a total consideration of €452,199,853.08. To date approximately 25.93% of the maximum total value of the share buyback...

Continue reading

Acarix accelerates US market entry with Proximo Medical as commercialization partner

  Press release (MAR)Malmö, Sweden, November 9, 2021 Acarix accelerates US market entry with Proximo Medical as commercialization partner Acarix today announced the signing of a Commercial Access agreement with Proximo Medical, LLC, to rapidly initiate the commercialization of the CADScor system in the US market. With the agreement, Acarix immediately gains market access and a senior cardiovascular sales force covering selected states in the US, as a complement to Acarix direct-to-market strategy. The CADScor® System is technology using AI and a smart sensor to rule out Coronary Artery Disease (CAD) in patients experiencing symptoms of suspected stable CAD. It is a non-invasive assessment and provides results to heath care professionals and patients in less than 10 minutes. With 9 out 10 patients undergoing CAD diagnostic testing not...

Continue reading

ERYTECH to Present at the 12th Annual Jefferies Global London Healthcare Conference

ERYTECH to Present at the 12th Annual Jefferies Global London Healthcare ConferenceIn-Person Dates: November 16th-17thVirtual Dates: November 18th-19thCambridge, MA (U.S.) and Lyon (France), November 9, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that its CEO, Gil Beyen, will participate in a fireside chat at the 12th Annual Jefferies London Healthcare Conference and invites investors to participate in one-on-one meetings both in-person on Tuesday and Wednesday, November 16th/17th or virtually on Thursday and Friday, November 18th/19th. Fireside ChatGil Beyen, Chief Executive Officer, will be participating in a fireside chat on Wednesday, November 17th at 11:20am (GMT). Those...

Continue reading

Rexel closes the acquisition of Mayer in the US

Rexel closes the acquisition of Mayer in the US Rexel, worldwide expert in the multichannel professional distribution of products and services for the energy world, announces the closing of the acquisition of 100% of Mayer in the US, marking a new strategic step to strengthen its presence in key markets. Headquartered in Birmingham, Alabama and founded in 1930, Mayer operates 68 branches in 12 states, with a strong presence in Alabama, Florida, Georgia and Pennsylvania. It counts 1,200 employees and generated turnover of USD1.2bn over the last twelve months through end-August 2021. ABOUT REXEL GROUP Rexel, worldwide expert in the multichannel professional distribution of products and services for the energy world, addresses three main markets – residential, commercial and industrial. The Group supports its residential, commercial...

Continue reading

Agfa-Gevaert Q3 results – Regulated information – November 9, 2021 – 7:45 a.m. CET

            Agfa-Gevaert in Q3 2021: decent top line recovery but increasing inflationary pressure and supply chain issuesDecent top line recovery but contrasted performance between the divisions Good margin performance versus Q3 2020 despite increasing inflationary pressure and supply chain issues Strong price actions in place as contracts allow Strict cost management maintained Adjusted EBITDA 35% higher than in the third quarter of 2020 Working capital stable as a percentage of sales despite raw material cost inflation and supply chain issuesMortsel (Belgium), November 9, 2021 – Agfa-Gevaert today commented on its results in the third quarter of 2021. “In the third quarter, we made good progress with several important steps in Agfa’s transformation process. At the end of October, we announced the intention to partner with Atos...

Continue reading

Sampo plc’s share buybacks 08/11/2021

SAMPO PLC                 STOCK EXCHANGE RELEASE         09/11/2021 at 08:30 am Sampo plc’s share buybacks 08/11/2021 On 08/11/2021 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  31,048 45.06 AQEU  44,672 45.03 CEUX  5,776 45.01 TQEX  72,076 45.04 XHELTOTAL 153,572 45.04  *rounded to two decimals                 On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.